Metropolis Healthcare Limited

BSE:542650 Stock Report

Market Cap: ₹111.1b

Metropolis Healthcare Valuation

Is 542650 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 542650 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 542650 (₹2167.55) is trading above our estimate of fair value (₹1137.68)

Significantly Below Fair Value: 542650 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 542650?

Key metric: As 542650 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 542650. This is calculated by dividing 542650's market cap by their current earnings.
What is 542650's PE Ratio?
PE Ratio75.1x
Earnings₹1.48b
Market Cap₹111.15b

Price to Earnings Ratio vs Peers

How does 542650's PE Ratio compare to its peers?

The above table shows the PE ratio for 542650 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average65.7x
VIJAYA Vijaya Diagnostic Centre
89.5x25.4%₹118.7b
539871 Thyrocare Technologies
63.1x26.9%₹53.0b
LALPATHLAB Dr. Lal PathLabs
62.9x13.6%₹252.6b
KRSNAA Krsnaa Diagnostics
47.1x35.5%₹32.6b
542650 Metropolis Healthcare
75.1x23.8%₹111.1b

Price-To-Earnings vs Peers: 542650 is expensive based on its Price-To-Earnings Ratio (75.1x) compared to the peer average (65.7x).

Price to Earnings Ratio vs Industry

How does 542650's PE Ratio compare vs other companies in the IN Healthcare Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.1xn/aUS$11.95m
No more companies available in this PE range
542650 75.1xIndustry Avg. 45.3xNo. of Companies6PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 542650 is expensive based on its Price-To-Earnings Ratio (75.1x) compared to the Indian Healthcare industry average (44.2x).

Price to Earnings Ratio vs Fair Ratio

What is 542650's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

542650 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio75.1x
Fair PE Ratio57.5x

Price-To-Earnings vs Fair Ratio: 542650 is expensive based on its Price-To-Earnings Ratio (75.1x) compared to the estimated Fair Price-To-Earnings Ratio (57.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 542650 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹2,167.55
₹2,152.41
-0.7%
13.5%₹2,650.00₹1,691.00n/a17
Nov ’25₹2,143.35
₹2,085.53
-2.7%
13.8%₹2,490.00₹1,691.00n/a17
Oct ’25₹2,250.70
₹2,065.24
-8.2%
13.4%₹2,490.00₹1,691.00n/a17
Sep ’25₹2,139.75
₹2,065.24
-3.5%
13.4%₹2,490.00₹1,691.00n/a17
Aug ’25₹2,085.85
₹1,932.82
-7.3%
13.1%₹2,300.00₹1,486.00n/a17
Jul ’25₹2,054.80
₹1,921.13
-6.5%
13.3%₹2,300.00₹1,486.00n/a16
Jun ’25₹1,905.90
₹1,894.56
-0.6%
15.5%₹2,300.00₹1,293.00n/a16
May ’25₹1,816.35
₹1,701.60
-6.3%
12.2%₹1,973.00₹1,341.00n/a15
Apr ’25₹1,731.30
₹1,668.69
-3.6%
12.2%₹1,969.00₹1,341.00n/a13
Mar ’25₹1,713.65
₹1,661.00
-3.1%
12.5%₹1,969.00₹1,341.00n/a13
Feb ’25₹1,631.00
₹1,600.69
-1.9%
12.2%₹1,865.00₹1,298.00n/a13
Jan ’25₹1,673.95
₹1,563.23
-6.6%
14.0%₹1,893.00₹1,230.00n/a13
Dec ’24₹1,686.90
₹1,563.23
-7.3%
14.0%₹1,893.00₹1,230.00n/a13
Nov ’24₹1,415.10
₹1,422.83
+0.5%
10.9%₹1,610.00₹1,087.00₹2,143.3512
Oct ’24₹1,459.05
₹1,410.33
-3.3%
11.5%₹1,650.00₹1,087.00₹2,250.7012
Sep ’24₹1,363.75
₹1,398.00
+2.5%
11.6%₹1,650.00₹1,087.00₹2,139.7513
Aug ’24₹1,381.55
₹1,381.31
-0.02%
12.9%₹1,670.00₹1,027.00₹2,085.8513
Jul ’24₹1,493.75
₹1,372.08
-8.1%
12.1%₹1,670.00₹1,027.00₹2,054.8013
Jun ’24₹1,306.65
₹1,370.50
+4.9%
11.7%₹1,670.00₹1,027.00₹1,905.9014
May ’24₹1,251.70
₹1,511.00
+20.7%
15.2%₹1,933.00₹1,250.00₹1,816.3513
Apr ’24₹1,248.95
₹1,528.85
+22.4%
14.4%₹1,933.00₹1,250.00₹1,731.3013
Mar ’24₹1,330.35
₹1,538.08
+15.6%
15.1%₹1,933.00₹1,250.00₹1,713.6513
Feb ’24₹1,306.40
₹1,652.29
+26.5%
14.2%₹1,978.00₹1,250.00₹1,631.0014
Jan ’24₹1,327.10
₹1,667.38
+25.6%
14.6%₹2,052.00₹1,250.00₹1,673.9513
Dec ’23₹1,476.70
₹1,667.38
+12.9%
14.6%₹2,052.00₹1,250.00₹1,686.9013
Nov ’23₹1,764.95
₹1,677.31
-5.0%
16.0%₹2,134.00₹1,165.00₹1,415.1013

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

N G Industries

₹578.8m

Provides various healthcare services in India.

530897

₹172.75

7D

2.1%

1Y

2.8%

Dr Lalchandani Labs

₹72.3m

Provides diagnostic and related healthcare tests and services in India.

541299

₹16.68

7D

-10.9%

1Y

n/a

Adeshwar Meditex

₹340.0m

Manufactures and exports sterile wound dressings, first aid kits, pharmaceuticals, and other medical disposables in India and internationally.

543309

₹23.56

7D

0%

1Y

-5.8%